(Q34249182)

English

Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

0 references

3

object named as

Tore K Kvien

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Maria K Kvamme

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Elisabeth Lie

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ivar S Kristiansen

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

25 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1618-1627

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Measuring Worker Productivity: Frameworks and Measures

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Systematic review of studies of productivity loss due to rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry).

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Annual costs of rheumatoid arthritis in Turkey

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Disease status, costs and quality of life of patients with rheumatoid arthritis in France: the ECO-PR Study.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Trends in economic consequences of rheumatoid arthritis over two subsequent years

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Socioeconomic impact of ankylosing spondylitis in Tunisia

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Socioeconomic burden of psoriatic arthritis in Hong Kong: direct and indirect costs and the influence of disease pattern

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

European biologicals registers: methodology, selected results and perspectives

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Some examples of regression towards the mean

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

The value of productivity: human-capital versus friction-cost method.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES074

21 January 2018

Identifiers

10.1093/RHEUMATOLOGY/KES074

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34249182&oldid=1544060912"